ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Nevertheless, as the inhibitors induce no significant increase of the microimpedance signal from BCR-ABL-negative cells, it is likely that the effects of TKIs on CML cell adhesion are prevalently due to BCR-ABL inhibition.